Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Zoladex 10.8 mg in Premenopausal Women with Symptomatic Uterine Fibroids
ChiCTR2000034693Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of goserelin in Fibromyoma (LM), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Percentage change in fibroid volume and Absolute change in fibroid volume. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
goserelin
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2000034693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034693.